{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:15:16Z","timestamp":1768320916979,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":2912,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1074\/jbc.m112.374611","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T02:08:00Z","timestamp":1346119680000},"page":"34970-34978","source":"Crossref","is-referenced-by-count":100,"title":["MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53\/Nanog"],"prefix":"10.1016","volume":"287","author":[{"given":"Cheng-Xiong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Permuth-Wey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Kruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Wenham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santo V.","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan M.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Q.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M112.374611_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs. Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.374611_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer. MiR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1470-2045(09)70343-2","article-title":"Relation between microRNA expression and progression and prognosis of gastric cancer. A microRNA expression analysis","volume":"11","author":"Ueda","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1074\/jbc.M112.374611_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biocel.2011.01.002","article-title":"Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells","volume":"43","author":"Qiang","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1074\/jbc.M112.374611_bib5","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/emboj.2011.102","article-title":"MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C","volume":"30","author":"Penna","year":"2011","journal-title":"EMBO J."},{"key":"10.1074\/jbc.M112.374611_bib6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.374611_bib7","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","article-title":"MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype","volume":"8","author":"Blenkiron","year":"2007","journal-title":"Genome Biol."},{"key":"10.1074\/jbc.M112.374611_bib8","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","article-title":"Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer","volume":"67","author":"Sempere","year":"2007","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells. An evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib10","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1158\/0008-5472.CAN-11-1035","article-title":"MicroRNA regulation of cancer stem cells","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Down-regulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.374611_bib12","doi-asserted-by":"crossref","first-page":"e6816","DOI":"10.1371\/journal.pone.0006816","article-title":"MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells","volume":"4","author":"Ji","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M112.374611_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nature07299","article-title":"MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation","volume":"455","author":"Tay","year":"2008","journal-title":"Nature"},{"key":"10.1074\/jbc.M112.374611_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.374611_bib15","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Jeter","year":"2011","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M112.374611_bib16","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/onc.2011.338","article-title":"Sox2 expression in breast tumours and activation in breast cancer stem cells","volume":"31","author":"Leis","year":"2012","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M112.374611_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/scd.2009.0113","article-title":"Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs","volume":"18","author":"Kashyap","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1074\/jbc.M112.374611_bib18","doi-asserted-by":"crossref","first-page":"52175","DOI":"10.1074\/jbc.M406802200","article-title":"Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M112.374611_bib19","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"Deng","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M112.374611_bib20","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1172\/JCI45273","article-title":"Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production","volume":"121","author":"McLean","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1074\/jbc.M112.374611_bib21","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-10-2388","article-title":"Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejca.2010.02.030","article-title":"Cancer stemness and metastasis. Therapeutic consequences and perspectives","volume":"46","author":"Monteiro","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/cr.2011.107","article-title":"Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1","volume":"21","author":"Moon","year":"2011","journal-title":"Cell Res."},{"key":"10.1074\/jbc.M112.374611_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs. MicroRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ncb1211","article-title":"p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression","volume":"7","author":"Lin","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1074\/jbc.M112.374611_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.cr.7310125","article-title":"Nanog and transcriptional networks in embryonic stem cell pluripotency","volume":"17","author":"Pan","year":"2007","journal-title":"Cell Res."},{"key":"10.1074\/jbc.M112.374611_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bjc.1997.412","article-title":"DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status","volume":"76","author":"De Feudis","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib28","first-page":"3927","article-title":"P53 enhances ascorbyl stearate-induced G2\/M arrest of human ovarian cancer cells","volume":"27","author":"Naidu","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1074\/jbc.M112.374611_bib29","first-page":"655","article-title":"Expression of p53 in cisplatin-resistant ovarian cancer cell lines. Modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)","volume":"5","author":"Hagopian","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib30","doi-asserted-by":"crossref","first-page":"e23383","DOI":"10.1371\/journal.pone.0023383","article-title":"Holoclone forming cells from pancreatic cancer cells enrich tumor-initiating cells and represent a novel model for study of cancer stem cells","volume":"6","author":"Tan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M112.374611_bib31","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/onc.2010.111","article-title":"TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214","volume":"29","author":"Yin","year":"2010","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M112.374611_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib33","doi-asserted-by":"crossref","first-page":"e2428","DOI":"10.1371\/journal.pone.0002428","article-title":"Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy","volume":"3","author":"Dylla","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M112.374611_bib34","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1158\/1078-0432.CCR-08-1479","article-title":"Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers","volume":"15","author":"Tanei","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/jbc.M112.374611_bib35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M112.374611_bib36","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M112.374611_bib37","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature08290","article-title":"The Ink4\/Arf locus is a barrier for iPS cell reprogramming","volume":"460","author":"Li","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M112.374611_bib38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Mari\u00f3n","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M112.374611_bib39","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.4161\/cc.8.19.9627","article-title":"The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.M112.374611_bib40","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2009.06.048","article-title":"The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells","volume":"138","author":"Cicalese","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.374611_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2008.11.006","article-title":"p53 regulates hematopoietic stem cell quiescence","volume":"4","author":"Liu","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1074\/jbc.M112.374611_bib42","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.4161\/cc.9.16.12598","article-title":"MiR-33-mediated down-regulation of p53 controls hematopoietic stem cell self-renewal","volume":"9","author":"Herrera-Merchan","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.M112.374611_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","article-title":"Assessing TP53 status in human tumours to evaluate clinical outcome","volume":"1","author":"Soussi","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M112.374611_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1953","article-title":"Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate","volume":"39","author":"Flynt","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.374611_bib45","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/nar\/gkn388","article-title":"Dispatched Homolog 2 is targeted by miR-214 through a combination of three weak microRNA recognition sites","volume":"36","author":"Li","year":"2008","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1074\/jbc.a112.374611","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"record-id":"404"},{"DOI":"10.1074\/jbc.a112.374611","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820626485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820626485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M112.374611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:47:14Z","timestamp":1641365234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820626485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":45,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0021925820626485"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m112.374611","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}